此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents

2026年8月3日 更新者:Dr. Carolyn Heckman, Ph.D、Rutgers, The State University of New Jersey

A Digital Skin Cancer Prevention Intervention for Adolescents and Their Parents

The goal of this pilot clinical trial is to learn if a digital intervention to improve sun safety, Sun Safe Together (SST), is feasible and acceptable to teenagers and their parents.

研究概览

详细说明

Melanoma is a leading cause of invasive cancer in teens and young adults aged 15-39. Most skin cancers are preventable with skin protection such as minimizing UVR exposure and wearing protective clothing and sunscreen. However, teens have low levels of sun protection. Thus, interventions targeting skin cancer risk reduction among teens are needed. The proposed Sun Safe Together (SST) intervention is a 12-week program consisting of sun safety and general health messages sent via multimedia messaging service (MMS) to teens and via a private Facebook group for parents.

This pilot trial is a single arm test of SST to determine:

  1. feasibility of enrolling parent-teen dyads
  2. engagement with/acceptability of the intervention via message views and acceptability ratings
  3. outcome data collection feasibility (i.e., daily diary, UVR exposure measured by UVR dosimeter)
  4. retention rates for teens and parents at 3 and 6 months

研究类型

介入性

注册 (估计的)

104

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • New Jersey
      • New Brunswick、New Jersey、美国、08901
        • 招聘中
        • Rutgers Cancer Institute
        • 接触:
        • 接触:
        • 首席研究员:
          • Carolyn J. Heckman, PhD
        • 首席研究员:
          • Katie A. Devine, PhD, MPH

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 孩子
  • 成人
  • 年长者

接受健康志愿者

是的

描述

Inclusion Criteria:

Parents and teens are participating as dyads, meaning both the parent and the teen need to be deemed eligible based on the criteria below to be able to participate.

Teens

  • Must be ages 13-17 years
  • Live with study parent equal to or greater than half time in US
  • Have experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score
  • Have no personal history of melanoma or severe medical condition that prevents participation
  • Have access to smartphone
  • Speak and read English

Parents/Guardians

  • Must be age 18 or older
  • Live with a teen equal to or greater than half time in US
  • Have a teen who had experienced sunburn or indoor tanned in the last year or have a suboptimal sun protection score
  • Have no personal history of melanoma or severe medical condition that prevents participation
  • Have internet at home, a Facebook account, and be willing to use Facebook daily
  • Have access to smartphone
  • Speak and read English

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Teen MMS & Parent Facebook Intervention
Teens will receive MMS messages regarding sun safety behaviors and other general health issues for 12 weeks.
Parents of teenagers join a private Facebook group where membership, activities, and content are only viewable by invited members. Content related to teen sun safety and general health will be posted for 12 weeks. Research staff will moderate the group.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Feasibility of recruitment
大体时间:Baseline
Feasibility of recruitment will be assessed by the proportion of eligible parent-teen dyads that enroll in the study
Baseline
Acceptability of MMS intervention
大体时间:Immediately after the intervention
Items were adapted from the Acceptability of Intervention and Feasibility of Intervention Measures to obtain participant feedback about the acceptability, feasibility, ease of use, and impact of the intervention. Individual items are rated on a 5-point likert scale from (1) Completely Disagree to (5) Completely Agree. Higher scores indicated greater acceptability.
Immediately after the intervention
Engagement with MMS intervention
大体时间:3-months
Proportion of messages viewed will be calculated to describe engagement.
3-months
Feasibility of Outcome Data Collection - 7-Day Diaries
大体时间:Baseline, 3-months, 6-months
Proportion of teens who complete 7-day diaries will be calculated.
Baseline, 3-months, 6-months
Feasibility of Outcome Data Collection - UVR Dosimeter
大体时间:Baseline, 6 months
Proportion of teens who return UVR dosimeter with usable data will be calculated.
Baseline, 6 months
Retention
大体时间:3-months, 6-months
Proportion of enrolled teens who complete surveys at 3- and 6-months will be calculated.
3-months, 6-months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Carolyn Heckman, PhD、Rutgers, The State University of New Jersey
  • 首席研究员:Katie A Devine, PhD、Rutgers, The State University of New Jersey

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年8月1日

初级完成 (估计的)

2027年12月1日

研究完成 (估计的)

2027年12月1日

研究注册日期

首次提交

2026年6月25日

首先提交符合 QC 标准的

2026年6月30日

首次发布 (实际的)

2026年7月2日

研究记录更新

最后更新发布 (实际的)

2026年8月5日

上次提交的符合 QC 标准的更新

2026年8月3日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • Pro2025001264
  • R34CA293237 (美国 NIH 拨款/合同)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

De-identified study data and associated documentation will be made available to the research community through the Data Sharing for Demographic Research (DSDR) data repository hosted at the Inter-university Consortium for Political and Social Research (ICPSR).

IPD 共享时间框架

Data will be made available by the time of associated publication or the end of grant funding (whichever is later). The duration of preservation and sharing of the data will be indefinite.

IPD 共享访问标准

De-identified human subject data will be made available in the Inter-university Consortium for Political and Social Research (ICPSR) data repository, which restricts access to the data to qualified investigators with an appropriate research question who complete a data use agreement and provide a data security plan.

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅